🇺🇸 Raltegravir (Use RAL as a simplification strategy) in United States

Raltegravir (Use RAL as a simplification strategy) (Raltegravir (Use RAL as a simplification strategy)) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Raltegravir (Use RAL as a simplification strategy) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in United States

Frequently asked questions

Is Raltegravir (Use RAL as a simplification strategy) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Raltegravir (Use RAL as a simplification strategy) in United States?

Hospital Carlos III, Madrid is the originator. The local marketing authorisation holder may differ — check the official source linked above.